• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏磁共振成像衍生的左心房特征与植入式心脏复律除颤器患者的房颤检测的关系。

Cardiac Magnetic Resonance Imaging-Derived Left Atrial Characteristics in Relation to Atrial Fibrillation Detection in Patients With an Implantable Cardioverter-Defibrillator.

机构信息

Department of Cardiology, Amsterdam UMC Vrije Universiteit Amsterdam, Amsterdam Cardiovascular Sciences Amsterdam the Netherlands.

出版信息

J Am Heart Assoc. 2023 Aug;12(15):e028014. doi: 10.1161/JAHA.122.028014. Epub 2023 Jul 25.

DOI:10.1161/JAHA.122.028014
PMID:37489727
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10492968/
Abstract

Background Among patients with an implantable cardioverter-defibrillator, a high prevalence of atrial fibrillation (AF) is present. Identification of AF predictors in this patient group is of clinical importance to initiate appropriate preventive therapeutic measures to reduce the risk of AF-related complications. This study assesses whether cardiac magnetic resonance imaging-derived atrial characteristics are associated with AF development in patients with a dual-chamber implantable cardioverter-defibrillator or cardiac resynchronization therapy defibrillator, as detected by the cardiac implantable electronic device. Methods and Results This single-center retrospective study included 233 patients without documented AF history at the moment of device implantation (dual-chamber implantable cardioverter-defibrillator [63.5%] or cardiac resynchronization therapy defibrillator [36.5%]). All patients underwent cardiac magnetic resonance imaging before device implantation. Cardiac magnetic resonance-derived features of left atrial (LA) remodeling were evaluated in all patients. Detection of AF episodes was based on cardiac implantable electronic device interrogation. During a median follow-up of 6.1 years, a newly diagnosed AF episode was detected in 88 of the 233 (37.8%) patients with an ICD. In these patients, increased LA volumes and impaired LA function (LA emptying fraction and LA strain) were found as compared with patients without AF during follow-up. However, a significant association was only found in patients with dilated cardiomyopathy and not in patients with ischemic cardiomyopathy. Conclusions LA remodeling characteristics were associated with development of AF in patients with dilated cardiomyopathy but not patients with ischemic cardiomyopathy, suggesting different mechanisms of AF development in ischemic cardiomyopathy and dilated cardiomyopathy. Assessment of LA remodeling before device implantation might identify high-risk patients for AF.

摘要

背景

在植入式心脏复律除颤器(ICD)患者中,心房颤动(AF)的患病率较高。在该患者群体中识别 AF 的预测因素对于启动适当的预防性治疗措施以降低 AF 相关并发症的风险具有重要的临床意义。本研究评估了心脏磁共振成像(CMR)衍生的心房特征是否与植入双腔 ICD 或心脏再同步治疗除颤器(CRT-D)患者的 AF 发展相关,这些特征由心脏植入式电子设备(CIED)检测到。

方法和结果

本单中心回顾性研究纳入了 233 例在装置植入时无记录 AF 病史的患者(双腔 ICD [63.5%]或 CRT-D [36.5%])。所有患者在装置植入前均进行 CMR 检查。所有患者均评估了左心房(LA)重构的 CMR 特征。基于 CIED 询问来检测 AF 发作。在中位随访 6.1 年期间,在 233 例 ICD 患者中有 88 例(37.8%)新诊断出 AF 发作。与随访期间未发生 AF 的患者相比,这些患者的 LA 容积增加和 LA 功能受损(LA 排空分数和 LA 应变)。然而,仅在扩张型心肌病患者中发现了显著相关性,而在缺血性心肌病患者中则没有。

结论

LA 重构特征与扩张型心肌病患者 AF 的发生相关,但与缺血性心肌病患者无关,这表明缺血性心肌病和扩张型心肌病中 AF 发生的机制不同。在装置植入前评估 LA 重构可能有助于识别发生 AF 的高危患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b64/10492968/ce561586a573/JAH3-12-e028014-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b64/10492968/2c6715f5ed0a/JAH3-12-e028014-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b64/10492968/fe843f14c2b8/JAH3-12-e028014-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b64/10492968/fcc86227db07/JAH3-12-e028014-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b64/10492968/ce561586a573/JAH3-12-e028014-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b64/10492968/2c6715f5ed0a/JAH3-12-e028014-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b64/10492968/fe843f14c2b8/JAH3-12-e028014-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b64/10492968/fcc86227db07/JAH3-12-e028014-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b64/10492968/ce561586a573/JAH3-12-e028014-g001.jpg

相似文献

1
Cardiac Magnetic Resonance Imaging-Derived Left Atrial Characteristics in Relation to Atrial Fibrillation Detection in Patients With an Implantable Cardioverter-Defibrillator.心脏磁共振成像衍生的左心房特征与植入式心脏复律除颤器患者的房颤检测的关系。
J Am Heart Assoc. 2023 Aug;12(15):e028014. doi: 10.1161/JAHA.122.028014. Epub 2023 Jul 25.
2
Impaired left atrial function predicts inappropriate shocks in primary prevention implantable cardioverter-defibrillator candidates.左心房功能受损可预测原发性预防植入式心脏复律除颤器候选者的不适当电击。
J Cardiovasc Electrophysiol. 2017 Jul;28(7):796-805. doi: 10.1111/jce.13234. Epub 2017 Jun 22.
3
Estimating the incidence of atrial fibrillation in single-chamber implantable cardioverter defibrillator patients.估算单腔植入式心脏复律除颤器患者心房颤动的发病率。
Pacing Clin Electrophysiol. 2019 Feb;42(2):132-138. doi: 10.1111/pace.13555. Epub 2018 Dec 13.
4
Clinical Outcomes and Characteristics With Dofetilide in Atrial Fibrillation Patients Considered for Implantable Cardioverter-Defibrillator.在考虑植入式心脏复律除颤器的房颤患者中,多非利特的临床转归和特征。
Circ Arrhythm Electrophysiol. 2020 Jul;13(7):e008168. doi: 10.1161/CIRCEP.119.008168. Epub 2020 Jun 14.
5
New atrial arrhythmia occurrence in single chamber implantable cardioverter defibrillator patients: A real-world investigation.单腔植入式心律转复除颤器患者新发房性心律失常的真实世界研究。
J Cardiovasc Electrophysiol. 2023 Feb;34(2):438-444. doi: 10.1111/jce.15790. Epub 2022 Dec 30.
6
Subclinical atrial fibrillation detection with a floating atrial sensing dipole in single lead implantable cardioverter-defibrillator systems: Results of the SENSE trial.单导联植入式心脏复律除颤器系统中使用浮动心房感知偶极检测亚临床房颤:SENSE试验结果
J Cardiovasc Electrophysiol. 2019 Oct;30(10):1994-2001. doi: 10.1111/jce.14081. Epub 2019 Aug 5.
7
Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.心脏磁共振成像对比经胸超声心动图对因原发性预防植入式心脏复律除颤器治疗评估而转诊的缺血性和非缺血性扩张型心肌病患者的预后益处。
Circ Cardiovasc Imaging. 2016 Oct;9(10). doi: 10.1161/CIRCIMAGING.115.004956.
8
The Dx-AF study: a prospective, multicenter, randomized controlled trial comparing VDD-ICD to VVI-ICD in detecting sub-clinical atrial fibrillation in defibrillator patients.Dx-AF研究:一项前瞻性、多中心、随机对照试验,比较VDD型植入式心律转复除颤器(VDD-ICD)与VVI型植入式心律转复除颤器(VVI-ICD)在检测除颤器患者亚临床房颤方面的效果。
J Interv Card Electrophysiol. 2017 Oct;50(1):57-63. doi: 10.1007/s10840-017-0276-0. Epub 2017 Jul 27.
9
Impact of atrial fibrillation on 1-year outcome in patients with implantable cardioverter defibrillator or cardiac resynchronization therapy with defibrillator: results from the German DEVICE Registry.心房颤动对植入式心脏复律除颤器或心脏再同步化治疗除颤器患者1年预后的影响:来自德国DEVICE注册研究的结果
J Thorac Dis. 2024 Mar 29;16(3):1825-1835. doi: 10.21037/jtd-23-274. Epub 2024 Mar 27.
10
The role of atrial sensing for new-onset atrial arrhythmias diagnosis and management in single-chamber implantable cardioverter-defibrillator recipients: Results from the THINGS registry.单腔植入式心律转复除颤器受者中新发房性心律失常诊断和管理中心房感知的作用:来自 THINGS 注册研究的结果。
J Cardiovasc Electrophysiol. 2020 Apr;31(4):846-853. doi: 10.1111/jce.14396. Epub 2020 Feb 25.

本文引用的文献

1
Impaired left atrial reservoir and conduit strain in patients with atrial fibrillation and extensive left atrial fibrosis.心房颤动伴广泛左房纤维化患者的左房储器和管道应变受损。
J Cardiovasc Magn Reson. 2021 Nov 11;23(1):131. doi: 10.1186/s12968-021-00820-6.
2
Left atrial fibrosis in atrial fibrillation: Mechanisms, clinical evaluation and management.心房颤动中的左心房纤维化:机制、临床评估与管理。
J Cell Mol Med. 2021 Mar;25(6):2764-2775. doi: 10.1111/jcmm.16350. Epub 2021 Feb 11.
3
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.
2020年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动诊断和管理指南:欧洲心脏病学会(ESC)心房颤动诊断和管理特别工作组,由ESC欧洲心律协会(EHRA)特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
4
The burden of atrial fibrillation and its prognostic value in patients with dilated cardiomyopathy.扩张型心肌病患者心房颤动的负担及其预后价值。
Kardiol Pol. 2020 Jan 24;78(1):37-44. doi: 10.33963/KP.15046. Epub 2019 Nov 4.
5
Subclinical atrial fibrillation detection with a floating atrial sensing dipole in single lead implantable cardioverter-defibrillator systems: Results of the SENSE trial.单导联植入式心脏复律除颤器系统中使用浮动心房感知偶极检测亚临床房颤:SENSE试验结果
J Cardiovasc Electrophysiol. 2019 Oct;30(10):1994-2001. doi: 10.1111/jce.14081. Epub 2019 Aug 5.
6
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation.退行性二尖瓣反流患者心房颤动的长期影响。
J Am Coll Cardiol. 2019 Jan 29;73(3):264-274. doi: 10.1016/j.jacc.2018.10.067.
7
Estimating the incidence of atrial fibrillation in single-chamber implantable cardioverter defibrillator patients.估算单腔植入式心脏复律除颤器患者心房颤动的发病率。
Pacing Clin Electrophysiol. 2019 Feb;42(2):132-138. doi: 10.1111/pace.13555. Epub 2018 Dec 13.
8
Myocardial Perfusion Is Impaired and Relates to Cardiac Dysfunction in Patients With Atrial Fibrillation Both Before and After Successful Catheter Ablation.心肌灌注受损与心房颤动患者导管消融前后的心脏功能障碍有关。
J Am Heart Assoc. 2018 Aug 7;7(15):e009218. doi: 10.1161/JAHA.118.009218.
9
Silent atrial fibrillation in patients with an implantable cardioverter defibrillator and coronary artery disease (INDICO AF) trial: study rationale and design.植入式心脏复律除颤器与冠状动脉疾病患者的无症状性心房颤动(INDICO AF)试验:研究原理与设计
Neth Heart J. 2018 Dec;26(12):628-633. doi: 10.1007/s12471-018-1185-2.
10
Atrial fibrillation and conduction system disease: the roles of catheter ablation and permanent pacing.心房颤动与传导系统疾病:导管消融与永久起搏的作用
J Interv Card Electrophysiol. 2018 Aug;52(3):395-402. doi: 10.1007/s10840-018-0429-9. Epub 2018 Aug 3.